The National Health Authorities grant this CoPP certificate upon request from the consumer, the authorities, or the drug supplier in the importing country. This certificate refers to a particular product whether or not it is sold in the country of origin
In the highly regulated pharmaceutical industry, obtaining a Certificate of Pharmaceutical Product (COPP) is crucial for manufacturers looking to import, license, or market their pharmaceutical products in India. The COPP is a certification that ensures compliance with the Indian Medical Device Regulations set forth by the Central Drugs Standard Control Organization (CDSCO). This comprehensive guide will walk you through the step-by-step process of obtaining a COPP in India, including the necessary documents, eligibility criteria, fee structure, and the benefits of acquiring this certification.
The National Health Authorities grant this CoPP certificate upon request from the consumer, the authorities, or the drug supplier in the importing country. This certificate refers to a particular product whether or not it is sold in the country of origin and also states that the manufacturer of the drug complies with GMP and that they are regularly inspected by the national health authorities
A CoPP is issued in the format which is recommended by WHO. It is the importing country which needs the CPP for the pharmaceutical product and a special type of certificate which allows the registration and marketing of a given pharmaceutical product in the exporting country of interest and forms sections of the application for marketing authorization. The CoPP is necessary when the drug is intended by the importing country for registration or renewal (licensing, authorization, or extension) for the scope of the product being sold or marketed in that country. A certificate has been recommended to assist the undersized drug regulatory authorities (DRA) or also without sufficient quality assurance (QA) facilities in WHO importing countries and also to determine the quality of pharmaceutical products according to import or registration requirements.
It is issued by the Inspectorate and the product supplier having GMP position and also the pharmaceutical, radiopharmaceutical, biological or veterinary drug status. The approved information is varied for various pharmaceutical formulations and strengths so it is often provided for a single product.
Objective of certification
A CoPP demonstrates that imported medication is of the relevant standard of quality, safety and efficacy to allow marketing, rigorous testing and inspection in the exporting country to be carried out by regulatory authorities and shows that it meets the relevant standards and procedures of Good Manufacturing Practice (GMP) and improves the product's quality and health.
Drugs for which COPP may be issued
Approved drug products
Active Pharmaceutical Ingredients (API)
Over the counter (OTC) drug product
Unapproved product
Homeopathic drug
To increase business in a foreign country it is necessary to obtain the COPP certificates by the pharmaceutical company
The person/company that exports the product must present a complete application for export certification.
The qualification is intended for a drug that meets the criteria of the Act or the criteria of the Food Drug and Cosmetic Act.
Process of obtaining the certificate
Send Form No. 3613b – Located on the FDA internet www.fda.gov/downloads/AboutFDA/Reports ManualsForms / Forms / UCM052388b) CoPP approval requirements:
Applicant Contact Information
Trade name (brand name of the drug product)
Bulk Material Generic Name
Applicant's name
Product License holder {List of manufacturing site on CPPP}
Full Manufacturing Facility Address
Facility Registration Number
Countries importing
Permission to release details
Number of certificates required
Certification Statement
Marketing status in the exporting country
Additional information
Foreign manufactured drugs Export certification from the country for the Foreign Manufacturing sites Approved drug products NDA, ANDA, BLA or approval Letter / Outer Container Label(s) / Package Insert / Package Container (Immediate)
Guideline for COPP form attachments:
All attachments will be required in two sets
Attachments should not be more than 5 pager
Applicant should consult with importing country for different types of information
COPP is generally issued within20 working days from the date of application and issued certificate expires in 2 years from the date of notarization.
Before initiating the registration process, it is important to determine whether your medical device or pharmaceutical product falls under the category of notified medical devices. The Drugs and Cosmetics Act, 1940, and Rules, 1945, regulate the import, manufacturing, sale, and distribution of medical devices in India. Currently, 22 notified medical devices require registration with the CDSCO. These include spinal needles, cochlear implants, annuloplasty rings, tracheostomy tubes, syringes and needles, dental implants, surgical sealants, heart valves, cardiac stents, orthopedic implants, endotracheal tubes, and catheters, among others. However, this list is not exhaustive, and it is important to consult the CDSCO for the most up-to-date information on notified medical devices.
Step 2: Appoint an Authorized Indian Agent
According to Indian regulations, foreign manufacturers must appoint an authorized Indian agent to act as their representative in India. The authorized Indian agent will serve as the point of contact for inspection authorities, assist in device approvals and registration processes, and handle vigilance/adverse event reporting. It is crucial to choose an authorized Indian agent who possesses a wholesale drug license (20B and 21B) and is licensed to either sell wholesale or manufacture drugs in India. The authorized Indian agent will liaise with the CDSCO's Medical Devices Division and ensure compliance with the registration process.
Step 3: Prepare and Submit the Regulatory Dossier
The next step in the COPP process is to prepare and submit the regulatory dossier to the CDSCO. The regulatory dossier includes essential documents and forms required for registration. Some of the key documents to be included in the dossier are:
Form 40: This form serves as the application form for registration and provides essential information about the medical device or pharmaceutical product.
TR6 Challan: A proof of payment for the CDSCO fees associated with the registration process.
Power of Attorney: A legal document authorizing the authorized Indian agent to act on behalf of the foreign manufacturer.
Schedule D(I): A list of all the notified medical devices and their respective classifications.
ISO 13485 Certificate: A certification demonstrating compliance with the international standard for medical device quality management systems.
Full Quality Assurance Certificate: A certificate indicating that the medical device or pharmaceutical product meets the required quality standards.
CE Design Certificate: A certificate issued by a European notified body confirming compliance with European Union regulations.
Declaration of Conformity: A document confirming that the medical device or pharmaceutical product complies with relevant regulations and standards.
Free Sale Certificate: A certificate issued by the regulatory authority of the exporting country, indicating that the product is freely sold in that country.
Certificate of Marketability from GHTF Countries: Additional certification from countries participating in the Global Harmonization Task Force (GHTF), indicating marketability of the product.
Other Regulatory Approvals: Any additional regulatory approvals obtained from relevant authorities.
Post-Market Surveillance (PMS) Report: A report detailing the surveillance activities conducted on the medical device or pharmaceutical product after it has been placed on the market.
Plant Master File: A comprehensive document providing detailed information about the manufacturing facility, processes, and quality control measures.
Device Master File: A compilation of technical information and specifications for the medical device.
Ensure that all documents are accurately completed, signed, and provided in the required format. Submit the regulatory dossier to the CDSCO along with the applicable fees. The CDSCO fees for a single manufacturing site are US $1500, and US $1000 for a single device family.
Step 4: Query Resolution and License Issuance
Upon submission of the regulatory dossier, the CDSCO will review the documents and may issue a query letter within approximately three months. It is important to promptly address the queries raised by the CDSCO to ensure a smooth registration process. Once all queries have been satisfactorily resolved, the CDSCO will issue the registration certificate in Form 41. The registration certificate is valid for a period of three years.
Step 5: Obtain an Import License
In addition to obtaining the registration certificate, foreign manufacturers must also obtain an import license to bring their medical device or pharmaceutical product into India. The import license application form, known as Form 10, should be completed and submitted directly by the distributor to the CDSCO. It is important to note that the import license is the regulatory permission required to import the product and comply with customs requirements. The import license is different from the import registration certificate, which is obtained earlier in the registration process.
Benefits of Obtaining a COPP in India
Acquiring a Certificate of Pharmaceutical Product (COPP) in India offers several benefits for manufacturers:
Market Access: The COPP ensures compliance with Indian regulations, allowing manufacturers to import, license, and market their medical devices or pharmaceutical products in India.
Regulatory Compliance: The COPP demonstrates adherence to quality standards and regulatory requirements, instilling confidence in healthcare professionals and consumers.
Streamlined Approval Process: By obtaining a COPP, manufacturers can streamline the approval process for their products, potentially reducing the time taken for market entry.
Competitive Advantage: Having a COPP enables manufacturers to compete effectively in the Indian market, ensuring their products meet the necessary regulatory standards and gain recognition among healthcare providers and patients.
Expansion Opportunities: With India's growing demand for high-quality medical devices and pharmaceutical products, obtaining a COPP opens doors for manufacturers to expand their business and tap into this lucrative market.
Documents Required for WHO-COPP Certificate Application from CDSCO
Application for WHO-GMP Certification & Issuance of COPP:
Applicant Details:
Name
Address
Telephone
Fax
Email
Manufacturing Details:
Copy of Manufacturing Licence
List of approved products
List of products with valid CoPP (For revalidation of CoPP)
List of products applied for issuance of COPP & their composition
Site Documentation:
Site Master file (as per WHO TRS 823)
Manufacturing Plant layout
Schematic diagram of water system (with circulation loop and MOC)
Schematic diagram of HVAC system (with terminal filter configuration)
Product Data:
Master manufacturing formula & process
Finished product specification & Method of Analysis
Stability study evaluation for 3 batches (Details as per Format-A)
Process validation report for 3 batches
Validation report of analytical method
Product summary sheet (as per Format B)
Actual labels of the products applied for WHO-CoPP
Certificates of Analysis for three batches of each product
Staff & Equipment Details:
List of technical staff (with qualification, experience, and approval status)
List of equipment and instruments
Operational Protocols:
List of SOPs (Standard Operating Procedures) and STPs (Standard Testing Procedures)
Export & Compliance:
Export data of the last 2 years (For re-validation of CoPP)
Proof of safety and effectiveness (As per Rule 158B of Drugs & Cosmetic Rules, 1945)
List of Reference standards/marker for all active ingredients/formulation
Undertaking regarding absence of non-herbal ingredients in products
Undertaking on compliance with domestic regulations (Drugs & Cosmetics Act, 1940, Drugs & Magic Remedies Act, 1954, etc.)
Obtaining a Certificate of Pharmaceutical Product (COPP) in India is a crucial step for manufacturers looking to import, license, and market their medical devices or pharmaceutical products in the country. The step-by-step process outlined in this guide provides a comprehensive overview of the requirements, documents, and procedures involved. It is essential to consult with experts and relevant authorities to ensure compliance with the latest regulations and guidelines. By successfully obtaining a COPP, manufacturers can gain market access, enhance their regulatory compliance, and seize opportunities in India's rapidly growing healthcare industry.
For more information and assistance with the COPP registration process in India, feel free to contact our experienced team of pharmaceutical consultants at +91 - 9999139391or [email protected].
STAGE 1
CONNECT WITH US
We are just a call or message away!
Call or WhatsApp us on +91-99991-39391 for free consultation from our team of experts. You can also email us on [email protected].
STAGE 2
PROCESS AND DOCUMENTATION
Your consent is essential!
We share the detailed and reasonable estimated costs, documents and prerequisites for the complete process before starting the process to ensure transparency.
STAGE 3
SHARE YOUR DOCUMENTS
We ensure timelines are met!
Our team warrants hassle free documentation. We collect the necessary documents and share the relevant drafts to ensure a timely filing and delivery.
STAGE 4
PROCESSING AND UPDATE
Precision is our speciality!
Upon collecting the necessary documents and information, we waste no time in preparation and filing of your application. development on your application is brought to your attention.
STAGE 5
SUCCESSFUL COMPLETION
We deliver what we commit!
On successful completion of the case we share all the relevant documents electronically and physically along with an assurance to pay you back if something is wrong.
At Corpzo, our clients’ success stories speak volumes. Discover how businesses across various industries have leveraged our expertise to achieve their goals. Read firsthand accounts of our commitment to excellence and the impact we've made in supporting their growth and compliance needs.
Working with Corpzo for our Alternative Investment Fund registration was a remarkable experience. Their deep understanding of regulatory requirements and meticulous attention to detail ensured a smooth and efficient process. The team was always available to address our queries and provided invaluable support at every step. With Corpzo's expertise, we successfully registered our AIF without any hurdles. Highly recommended for anyone navigating the complexities of AIF registration!
At Corpzo, we are dedicated to empowering our clients with valuable knowledge and insights. Our team of experts regularly shares in-depth articles, comprehensive guides, and industry updates on Knowledge Varsity. Whether you're looking for the latest trends in alternative investment funds or need expert advice on navigating the complexities of drug licensing, our resources are designed to keep you informed and ahead of the curve. We believe that informed clients make better decisions, and our goal is to provide you with the expertise you need to succeed.